We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
726
DELISTED
KalVista Pharmaceuticals
KALV
| $1.15M | ﹤0.01% |
57,296
-8,297
| -13% | -$134K |
|
727
Vitesse Energy
VTS
$663M
| $1.15M | ﹤0.01% |
63,106
+28,109
| +80% | +$566K |
|
728
LGI Homes
LGIH
$1.34B
| $1.14M | ﹤0.01% |
28,880
-4,359
| -13% | -$212K |
|
729
Insulet
PODD
$11B
| $1.14M | ﹤0.01% |
5,435
-2,138
| -28% | -$537K |
|
730
Packaging Corp of America
PKG
$20.3B
| $1.14M | ﹤0.01% |
5,349
-2,137
| -29% | -$477K |
|
731
Deckers Outdoor
DECK
$14.2B
| $1.13M | ﹤0.01% |
11,279
-5,855
| -34% | -$628K |
|
732
Fortive
FTV
$18.4B
| $1.13M | ﹤0.01% |
20,410
-7,884
| -28% | -$442K |
|
733
International Paper
IP
$20.2B
| $1.13M | ﹤0.01% |
31,602
-12,621
| -29% | -$524K |
|
734
CytomX Therapeutics
CTMX
$725M
| $1.13M | ﹤0.01% |
239,824
-33,760
| -12% | -$171K |
|
735
Annexon
ANNX
$857M
| $1.13M | ﹤0.01% |
203,269
+61,625
| +44% | +$347K |
|
736
Healthpeak Properties
DOC
$15.3B
| $1.12M | ﹤0.01% |
68,386
-21,466
| -24% | -$368K |
|
737
Ralph Lauren
RL
$23B
| $1.12M | ﹤0.01% |
3,262
-1,284
| -28% | -$456K |
|
|
CRWV
738
CoreWeave
CRWV
$45.1B
| $1.12M | ﹤0.01% |
14,478
+7,204
| +99% | +$625K |
|
739
Enterprise Financial Services Corp
EFSC
$2.4B
| $1.12M | ﹤0.01% |
20,632
-2,842
| -12% | -$160K |
|
740
Align Technology
ALGN
$12.4B
| $1.11M | ﹤0.01% |
6,500
-3,132
| -33% | -$549K |
|
741
International Flavors & Fragrances
IFF
$19.7B
| $1.11M | ﹤0.01% |
15,325
-6,121
| -29% | -$449K |
|
742
Amcor
AMCR
$20B
| $1.1M | ﹤0.01% |
27,654
-11,011
| -28% | -$487K |
|
743
Lakeland Financial Corp
LKFN
$1.53B
| $1.1M | ﹤0.01% |
19,112
+376
| +2% | +$22.1K |
|
744
TFS Financial
TFSL
$5.12B
| $1.1M | ﹤0.01% |
77,976
+8,306
| +12% | +$117K |
|
745
Kura Oncology
KURA
$936M
| $1.09M | ﹤0.01% |
134,152
-53,239
| -28% | -$457K |
|
746
AAR Corp
AIR
$5.07B
| $1.09M | ﹤0.01% |
9,932
+960
| +11% | +$103K |
|
747
Lennar Class B
LEN.B
$19.4B
| $1.08M | ﹤0.01% |
12,873
-1,871
| -13% | -$188K |
|
748
Cooper Companies
COO
$13.7B
| $1.08M | ﹤0.01% |
15,144
-6,260
| -29% | -$495K |
|
749
Tyson Foods
TSN
$20.1B
| $1.08M | ﹤0.01% |
16,885
-6,821
| -29% | -$424K |
|
750
Inhibrx
INBX
$1.26B
| $1.06M | ﹤0.01% |
15,761
+7,179
| +84% | +$533K |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.